Ken Griffin Smith & Nephew PLC Call Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$25.36 - $28.88 $245,992 - $280,136	-9,700 Reduced 77.6%	2,800 $71,000
Q4 2023 Feb 14, 2024	BUY	$21.55 - $27.43 $64,650 - $82,290	3,000 Added 31.58%	12,500 $341,000
Q3 2023 Nov 14, 2023	SELL	$24.33 - $31.28 $214,103 - $275,264	-8,800 Reduced 48.09%	9,500 $235,000
Q2 2023 Aug 14, 2023	BUY	$28.08 - $32.7 $78,624 - $91,560	2,800 Added 18.06%	18,300 $590,000
Q1 2023 May 15, 2023	SELL	$27.29 - $29.4 $185,572 - $199,920	-6,800 Reduced 30.49%	15,500 $432,000

Q4 2022 Feb 14, 2023	SELL	$22.3 - $27.91 $929,910 - $1.16 Million	-41,700 Reduced 65.16%	22,300 $599,000
Q3 2022 Nov 14, 2022	BUY	$12.1 - $29.35 $660,660 - $1.6 Million	54,600 Added 580.85%	64,000 $1.49 Million

222

31.5M

2.8K

51.7K

Ticker SNN
Exchange OTC
Sector Healthcare
Industry Medical Devices
Shares Outstandng 435,348,000
Market Cap $11.8B
Description
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabi...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.